MétaCan
Menu
Back to cohort
Record W3170831652 · doi:10.1016/j.esmoop.2021.100170

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

2021· review· en· W3170831652 on OpenAlexafffund
Silvia Stacchiotti, Aisha Miah, Anna Maria Frezza, Christina Messiou, Carlo Morosi, Augusto Caraceni, Cristina R. Antonescu, Jyoti Bajpai, Elizabeth H. Baldini, Sebastian Bauer, R. Biagini, Stefan Bielack, Jean‐Yves Blay, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Kjetil Boye, Thomas Brodowicz, Dario Callegaro, M. Deoras-Sutliff, Armelle Dufresne, Mikael Eriksson, Costantino Errani, А. А. Феденко, Virginia Ferraresi, Andrea Ferrari, Christopher D.�M. Fletcher, Xavier García del Muro, Hans Gelderblom, Rebecca A. Gladdy, F. Gouin, Giovanni Grignani, J. Gutkovich, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Paul H. Huang, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Bernd Kasper, Akira Kawai, Axel Le Cesne, Franel Le Grange, Andreas Leithner, Hugh Leonard, Javier Martín‐Broto, Ofer Merimsky, Priscilla Merriam, Rosalba Miceli, Olivier Mir, Michele Molinari, Michael Montemurro, Graziano Oldani, Emanuela Palmerini, Maria A. Pantaleo, S. Patel, Sophie Piperno‐Neumann, Chandrajit P. Raut, Vinod Ravi, Albiruni R. Abdul Razak, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Gonzalo Sapisochín, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, William D. Tap, Annalisa Trama, Andrew Tweddle, Winette T.A. van der Graaf, Michiel A. J. van de Sande, Winan J. van Houdt, G. van Oortmerssen, Andrew J. Wagner, Markus Wartenberg, Jayne Wood, Nadia Zaffaroni, Camilla Zimmermann, Paolo G. Casali, Angelo Paolo Dei Tos, Alessandro Gronchi

Bibliographic record

VenueESMO Open · 2021
Typereview
Languageen
FieldMedicine
TopicVascular Tumors and Angiosarcomas
Canadian institutionsPrincess Margaret Cancer CentreLunenfeld-Tanenbaum Research InstituteUniversity of Toronto
FundersMerck Sharp and DohmeJohnson and JohnsonPharmaMarEuropean Society for Medical OncologyAstellas PharmaEisaiDaiichi-SankyoCancer Research UKMedImmuneSanofiCanadian Aeronautics and Space InstituteMerckSarcoma UKDesmoid Tumor Research FoundationRocheNovartisGlaxoSmithKlineBoehringer IngelheimAmgenPfizerAimmune TherapeuticsAstraZenecaBristol-Myers SquibbEli Lilly and CompanyDaiichi Sankyo EuropeNational Cancer InstituteBayer
KeywordsEpithelioid hemangioendotheliomaMedicineCancerPathologyInternal medicine

Abstract

fetched live from OpenAlex

Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. No active systemic agents are currently approved specifically for EHE, which is typically refractory to the antitumor drugs used in sarcomas. The degree of uncertainty in selecting the most appropriate therapy for EHE patients and the lack of guidelines on the clinical management of the disease make the adoption of new treatments inconsistent across the world, resulting in suboptimal outcomes for many EHE patients. To address the shortcoming, a global consensus meeting was organized in December 2020 under the umbrella of the European Society for Medical Oncology (ESMO) involving >80 experts from several disciplines from Europe, North America and Asia, together with a patient representative from the EHE Group, a global, disease-specific patient advocacy group, and Sarcoma Patient EuroNet (SPAEN). The meeting was aimed at defining, by consensus, evidence-based best practices for the optimal approach to primary and metastatic EHE. The consensus achieved during that meeting is the subject of the present publication.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.024
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.015
Threshold uncertainty score0.080

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0150.024
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0050.005
Science and technology studies0.0010.001
Scholarly communication0.0030.004
Open science0.0030.002
Research integrity0.0050.004
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.130
GPT teacher head0.406
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations183
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueESMO OpenSame topicVascular Tumors and AngiosarcomasFrench-language works237,207